Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products.

Lilly said Thursday it will expand a Kenosha County, Wisconsin, factory it bought early this year, and the investment will help meet growing demand for injectable products like its diabetes and obesity drugs, Mounjaro and .

The ºÃÉ«tv Press. All rights reserved.

More Health Stories

Sign Up to Newsletters

Get the latest from ºÃÉ«tvNews in your inbox. Select the emails you're interested in below.